Page last updated: 2024-08-22

flupenthixol and Invasiveness, Neoplasm

flupenthixol has been researched along with Invasiveness, Neoplasm in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Apolito, K; Chen, S; Hait, WN; Miletti-González, KE; Muthukumaran, N; Rodríguez-Rodríguez, L; Saglimbeni, GN; Shih, WJ; Wu, X; Yang, J1
Hait, WN; Liao, J; Medina, DJ; Vassil, AD; Yang, GY; Yang, JM1

Other Studies

2 other study(ies) available for flupenthixol and Invasiveness, Neoplasm

ArticleYear
The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer.
    Cancer research, 2005, Aug-01, Volume: 65, Issue:15

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Membrane; Cell Movement; Drug Resistance, Neoplasm; Female; Flupenthixol; Humans; Hyaluronan Receptors; Immunoprecipitation; Neoplasm Invasiveness; Neoplasms; RNA Interference; Transfection

2005
Treatment of multidrug resistant (MDR1) murine leukemia with P-glycoprotein substrates accelerates the course of the disease.
    Biochemical and biophysical research communications, 1999, Dec-09, Volume: 266, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Cell Movement; Disease Progression; Drug Resistance, Neoplasm; Female; Flupenthixol; Humans; Hydrogen-Ion Concentration; Leukemia P388; Liver Neoplasms; Mechlorethamine; Mice; Neoplasm Invasiveness; Neoplasm Transplantation; Paclitaxel; Survival Rate; Tumor Cells, Cultured; Vincristine

1999